Molina Healthcare (NYSE:MOH) Stock: Insider Dale Wolf Sells 1,600 Shares

Key Points

• Director Dale Wolf sold 1,600 Molina Healthcare shares for about $329,792 at an average price of $206.12, reducing his direct holdings by 10.04% to 14,337 shares.
• Molina reported quarterly EPS of $0.89, beating the $0.79 consensus, and revenue of $11.08 billion versus expectations of $10.86 billion; revenue was down 3.4% year over year.
• Analysts hold a consensus “Hold” rating, with an average price target of $213.88. Shares ended Friday at $209.37, down 0.2%.

Molina Healthcare, Inc (NYSE:MOH - Get Free Report) Director Dale Wolf sold 1,600 shares of the business's stock in a transaction that occurred on Friday, November 13th. The stock was sold at an average price of $206.12, for a total value of $329,792.00. Following the completion of the sale, the director directly owned 14,337 shares in the company, valued at approximately $2,955,142.44. This represents a 10.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Molina Healthcare Stock Down 0.2%

MOH stock traded down $0.48 on Friday, reaching $209.37. 362,848 shares of the company traded hands, compared to its average volume of 1,260,886. Molina Healthcare, Inc has a one year low of $121.06 and a one year high of $244.89. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.69 and a quick ratio of 1.69. The company has a market cap of $10.93 billion, a P/E ratio of -218.09, a price-to-earnings-growth ratio of 12.34 and a beta of 0.75. The firm has a fifty day simple moving average of $202.43 and a 200-day simple moving average of $185.57.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The company reported $0.89 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.79 by $0.10. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The business had revenue of $11.08 billion during the quarter, compared to analysts' expectations of $10.86 billion. During the same quarter in the previous year, the business earned $1.84 earnings per share. The firm's quarterly revenue was down 3.4% compared to the same quarter last year. Research analysts anticipate that Molina Healthcare, Inc will post 5.30 earnings per share for the current year.

Institutional Investors Weigh In On Molina Healthcare

Several large investors have recently bought and sold shares of the business. Fortitude Family Office LLC boosted its stake in shares of Molina Healthcare by 63.7% in the 3rd quarter. Fortitude Family Office LLC now owns 131 shares of the company's stock worth $25,000 after buying an additional 51 shares during the last quarter. Elevation Wealth Partners LLC increased its position in Molina Healthcare by 118.2% during the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company's stock valued at $33,000 after acquiring an additional 78 shares during the last quarter. Global Retirement Partners LLC purchased a new stake in Molina Healthcare during the second quarter valued at $39,000. Versant Capital Management Inc increased its position in Molina Healthcare by 341.6% during the second quarter. Versant Capital Management Inc now owns 340 shares of the company's stock valued at $78,000 after acquiring an additional 263 shares during the last quarter. Finally, Contravisory Investment Management Inc. bought a new position in Molina Healthcare in the second quarter valued at about $89,000. 98.50% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on MOH. Barclays lowered their price target on Molina Healthcare from $180.00 to $178.00 and set an "underweight" rating for the company in a research report on Friday, October 23rd. Mizuho set a $255.00 price objective on shares of Molina Healthcare in a research report on Friday, October 23rd. Wells Fargo & Company reduced their price objective on shares of Molina Healthcare from $235.00 to $220.00 and set an "equal weight" rating for the company in a research note on Tuesday, July 28th. Royal Bank Of Canada raised their price objective on shares of Molina Healthcare from $218.00 to $222.00 and gave the company a "sector perform" rating in a research note on Friday, October 23rd. Finally, Jefferies Financial Group reaffirmed a "hold" rating and issued a $220.00 target price on shares of Molina Healthcare in a report on Friday, October 23rd. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $213.88.

About Molina Healthcare

Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.